HEAL — Restart Life Sciences Balance Sheet
0.000.00%
Last trade - 00:00- CA$3.42m
- CA$3.16m
Annual balance sheet for Restart Life Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2.14 | 0.219 | 0.267 | 0.008 | 0.17 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.017 | 0.07 | 0.008 | 0.007 | 0.011 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2.58 | 0.328 | 0.282 | 0.02 | 0.181 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.023 | 0.018 | 0.014 | 0.011 | 0.009 |
| Long Term Investments | |||||
| Total Assets | 3.05 | 0.881 | 0.297 | 0.031 | 0.19 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.383 | 0.422 | 0.255 | 0.842 | 0.489 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.383 | 0.422 | 0.255 | 0.842 | 0.489 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 2.66 | 0.459 | 0.041 | -0.811 | -0.299 |
| Total Liabilities & Shareholders' Equity | 3.05 | 0.881 | 0.297 | 0.031 | 0.19 |
| Total Common Shares Outstanding |